scholarly article | Q13442814 |
P50 | author | Marc Vidal | Q81911349 |
P2093 | author name string | Michael E Cusick | |
Song Yi | |||
Benoit Charloteaux | |||
Quan Zhong | |||
Nidhi Sahni | |||
Noor Jailkhani | |||
P2860 | cites work | Identification of a calcium channel modulator using a high throughput yeast two-hybrid screen | Q77463629 |
Huntingtin interacting proteins are genetic modifiers of neurodegeneration | Q21145230 | ||
Towards a proteome-scale map of the human protein–protein interaction network | Q21735930 | ||
Human Cancer Syndromes: Clues to the Origin and Nature of Cancer | Q22242264 | ||
Viral immune modulators perturb the human molecular network by common and unique strategies | Q24293704 | ||
The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability | Q24296476 | ||
Global landscape of HIV-human protein complexes | Q24300336 | ||
The role of PACT in the RNA silencing pathway | Q24301564 | ||
Identification of FAM111A as an SV40 host range restriction and adenovirus helper factor | Q24301654 | ||
A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease | Q24304932 | ||
Comparison of an expanded ataxia interactome with patient medical records reveals a relationship between macular degeneration and ataxia | Q24307380 | ||
A protein domain-based interactome network for C. elegans early embryogenesis | Q24322661 | ||
An empirical framework for binary interactome mapping | Q24322723 | ||
A human protein-protein interaction network: a resource for annotating the proteome | Q24324450 | ||
Mutant p53 interactome identifies nardilysin as a p53R273H-specific binding partner that promotes invasion | Q24337116 | ||
A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration | Q24337490 | ||
Genetic Control of Biochemical Reactions in Neurospora | Q24522198 | ||
WW domains of Nedd4 bind to the proline-rich PY motifs in the epithelial Na+ channel deleted in Liddle's syndrome | Q24563029 | ||
Genetic characterization of a mammalian protein-protein interaction domain by using a yeast reverse two-hybrid system | Q24596103 | ||
Reverse two-hybrid and one-hybrid systems to detect dissociation of protein-protein and DNA-protein interactions | Q24596251 | ||
Five years of GWAS discovery | Q24610574 | ||
Splitting p63 | Q24632741 | ||
High-quality binary protein interaction map of the yeast interactome network | Q24651397 | ||
The retromer subunit Vps26 has an arrestin fold and binds Vps35 through its C-terminal domain | Q24673655 | ||
A novel high-throughput (HTP) cloning strategy for site-directed designed chimeragenesis and mutation using the Gateway cloning system | Q24816500 | ||
Protein-protein interactions and networks: forward and reverse edgetics. | Q54352505 | ||
Mutation detection by a two-hybrid assay | Q59843183 | ||
Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review | Q27008867 | ||
ENU-induced mutation in the DNA-binding domain of KLF3 reveals important roles for KLF3 in cardiovascular development and function in mice | Q27321425 | ||
A transforming mutation in the pleckstrin homology domain of AKT1 in cancer | Q27646556 | ||
Mammalian Ras interacts directly with the serine/threonine kinase Raf | Q27860833 | ||
Network biology: understanding the cell's functional organization | Q27861027 | ||
Defining protein interactions with yeast actin in vivo | Q27934111 | ||
A high resolution protein interaction map of the yeast Mediator complex | Q27936324 | ||
Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins | Q28117120 | ||
The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest | Q28131694 | ||
A protein interaction map of Drosophila melanogaster | Q28131783 | ||
Assembly of Cell Regulatory Systems Through Protein Interaction Domains | Q28155799 | ||
AnotherTWIST on Baller-Gerold syndrome | Q28213315 | ||
Network modeling links breast cancer susceptibility and centrosome dysfunction | Q28252491 | ||
Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1 | Q28272543 | ||
Involvement of lipid rafts in nephrin phosphorylation and organization of the glomerular slit diaphragm | Q28350870 | ||
Missense mutation in the second RNA binding domain reveals a role for Prkra (PACT/RAX) during skull development | Q28478412 | ||
Three-dimensional reconstruction of protein networks provides insight into human genetic disease | Q28530021 | ||
An ARF-Independent c-MYC-Activated Tumor Suppression Pathway Mediated by Ribosomal Protein-Mdm2 Interaction | Q28590794 | ||
A map of the interactome network of the metazoan C. elegans | Q29547482 | ||
Interactome networks and human disease | Q29615773 | ||
Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease | Q29619085 | ||
Characterization of disease-associated single amino acid polymorphisms in terms of sequence and structure properties. | Q30329486 | ||
Loss of protein structure stability as a major causative factor in monogenic disease. | Q30351402 | ||
Genotype-phenotype correlations in von Hippel-Lindau disease. | Q30357251 | ||
Protein interactions in human genetic diseases. | Q30367185 | ||
Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signaling | Q30419809 | ||
Mass spectrometry supported determination of protein complex structure | Q30428635 | ||
Automated yeast two-hybrid screening for nuclear receptor-interacting proteins | Q33209988 | ||
Mutations that disrupt PHOXB interaction with the neuronal calcium sensor HPCAL1 impede cellular differentiation in neuroblastoma | Q33693337 | ||
Variability in gene expression underlies incomplete penetrance | Q33717980 | ||
'Edgetic' perturbation of a C. elegans BCL2 ortholog | Q33832092 | ||
Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer | Q34081324 | ||
Genetic analysis of von Hippel-Lindau disease. | Q34098432 | ||
Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias. | Q34205528 | ||
An experimentally derived confidence score for binary protein-protein interactions | Q34292333 | ||
Beyond hairballs: The use of quantitative mass spectrometry data to understand protein-protein interactions | Q34308163 | ||
Viral perturbations of host networks reflect disease etiology | Q34325431 | ||
Distilling pathophysiology from complex disease genetics | Q34574912 | ||
High-throughput cloning and expression library creation for functional proteomics | Q34606151 | ||
Empirically controlled mapping of the Caenorhabditis elegans protein-protein interactome network | Q34676654 | ||
Dynamic modularity in protein interaction networks predicts breast cancer outcome | Q34934057 | ||
Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorder | Q35043972 | ||
Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis | Q35168290 | ||
Protein interactome reveals converging molecular pathways among autism disorders | Q35203610 | ||
Structural basis of protein-protein interactions | Q35738224 | ||
Human and mouse TPIT gene mutations cause early onset pituitary ACTH deficiency | Q35964450 | ||
Cutaneous β-human papillomavirus E6 proteins bind Mastermind-like coactivators and repress Notch signaling. | Q36061599 | ||
Comprehensive Analysis of Host Cellular Interactions with Human Papillomavirus E6 Proteins Identifies New E6 Binding Partners and Reflects Viral Diversity | Q36414593 | ||
Proteomic approaches to the study of papillomavirus-host interactions. | Q36468283 | ||
Domains, motifs, and scaffolds: the role of modular interactions in the evolution and wiring of cell signaling circuits. | Q36498348 | ||
FAM111A mutations result in hypoparathyroidism and impaired skeletal development | Q36909275 | ||
Missense substitutions in the GAS1 protein present in holoprosencephaly patients reduce the affinity for its ligand, SHH | Q36963707 | ||
Dissecting disease inheritance modes in a three-dimensional protein network challenges the "guilt-by-association" principle | Q37010382 | ||
Protein networks in disease | Q37125547 | ||
Cross-species protein interactome mapping reveals species-specific wiring of stress response pathways | Q37184407 | ||
Literature-curated protein interaction datasets. | Q37196237 | ||
Multimodal assessment of protein functional deficiency supports pathogenicity of BRCA1 p.V1688del | Q37356517 | ||
How the Rb tumor suppressor structure and function was revealed by the study of Adenovirus and SV40. | Q37371276 | ||
A model of developmental evolution: selection, pleiotropy and compensation. | Q37990117 | ||
Interactome mapping for analysis of complex phenotypes: Insights from benchmarking binary interaction assays | Q38010411 | ||
Human diseases through the lens of network biology | Q38065572 | ||
Genotype to phenotype: lessons from model organisms for human genetics | Q38077445 | ||
Altered RNA binding activity underlies abnormal thyroid hormone metabolism linked to a mutation in selenocysteine insertion sequence-binding protein 2. | Q38297793 | ||
Evidence for Network Evolution in an Arabidopsis Interactome Map | Q38367823 | ||
Predisposition to relapsing nephrotic syndrome by a nephrin mutation that interferes with assembly of functioning microdomains | Q39851276 | ||
Edgetic perturbation models of human inherited disorders | Q42124353 | ||
Phenotypes of patients with "simple" Mendelian disorders are complex traits: thresholds, modifiers, and systems dynamics | Q42576797 | ||
High-quality binary interactome mapping | Q42858941 | ||
The folding and evolution of multidomain proteins | Q47599342 | ||
Exome and whole-genome sequencing for gene discovery: The future is now! | Q51620246 | ||
A functional assay for heterozygous mutations in the GTPase activating protein related domain of the neurofibromatosis type 1 gene. | Q52511818 | ||
P433 | issue | 6 | |
P921 | main subject | phenotype | Q104053 |
P304 | page(s) | 649-657 | |
P577 | publication date | 2013-11-26 | |
P1433 | published in | Current Opinion in Genetics & Development | Q13505684 |
P1476 | title | Edgotype: a fundamental link between genotype and phenotype | |
P478 | volume | 23 |
Q28550391 | A Pan-Cancer Catalogue of Cancer Driver Protein Interaction Interfaces |
Q30390381 | A Split-Ubiquitin Based Strategy Selecting for Protein Complex-Interfering Mutations |
Q64102377 | A network-centric approach to drugging TNF-induced NF-κB signaling |
Q47205509 | A systematic atlas of chaperome deregulation topologies across the human cancer landscape |
Q28542982 | Analysis of individual protein regions provides novel insights on cancer pharmacogenomics |
Q38899318 | Annexin A2 is SUMOylated on its N-terminal domain: regulation by insulin |
Q28083558 | Applications of comparative evolution to human disease genetics |
Q34117231 | Assemblages: functional units formed by cellular phase separation |
Q47693396 | Base-resolution stratification of cancer mutations using functional variomics. |
Q35789759 | Big-data-based edge biomarkers: study on dynamical drug sensitivity and resistance in individuals. |
Q60922225 | Capturing variation impact on molecular interactions in the IMEx Consortium mutations data set |
Q27305647 | Community structure analysis of transcriptional networks reveals distinct molecular pathways for early- and late-onset temporal lobe epilepsy with childhood febrile seizures |
Q45943371 | Computer-aided biomarker discovery for precision medicine: data resources, models and applications. |
Q64240621 | Convergent perturbation of the human domain-resolved interactome by viruses and mutations inducing similar disease phenotypes |
Q41007754 | Diagnosing phenotypes of single-sample individuals by edge biomarkers |
Q92643628 | Domain-mediated interactions for protein subfamily identification |
Q104567478 | Dynamic 3D proteomes reveal protein functional alterations at high resolution in situ |
Q92034887 | Estimating dispensable content in the human interactome |
Q47285564 | Extended linkers improve the detection of PPIs by DHFR PCA in living cells |
Q26773100 | Forward Individualized Medicine from Personal Genomes to Interactomes |
Q39201399 | Functional variomics and network perturbation: connecting genotype to phenotype in cancer. |
Q26774978 | Fundamentals of protein interaction network mapping |
Q89238692 | Gene Regulatory Network Perturbation by Genetic and Epigenetic Variation |
Q35549685 | Genetic perturbations that impair functional trait interactions lead to reduced bone strength and increased fragility in mice |
Q38797075 | Genetics of Combined Pituitary Hormone Deficiency: Roadmap into the Genome Era. |
Q35951692 | Genome and network visualization facilitates the analyses of the effects of drugs and mutations on protein-protein and drug-protein networks |
Q28607523 | Hand/foot splitting and the 're-evolution' of mesopodial skeletal elements during the evolution and radiation of chameleons |
Q50017200 | Identification of novel diagnostic biomarkers for thyroid carcinoma |
Q31038202 | Identifying network-based biomarkers of complex diseases from high-throughput data |
Q102220241 | Inferring the molecular and phenotypic impact of amino acid variants with MutPred2 |
Q90478903 | Integrating molecular networks with genetic variant interpretation for precision medicine |
Q38887068 | MSX1 mutations and associated disease phenotypes: genotype-phenotype relations |
Q36946554 | Modular transcriptional repertoire and MicroRNA target analyses characterize genomic dysregulation in the thymus of Down syndrome infants |
Q36214423 | PCAN: phenotype consensus analysis to support disease-gene association |
Q40384986 | PPIXpress: construction of condition-specific protein interaction networks based on transcript expression |
Q64986488 | Pathway-specific protein domains are predictive for human diseases. |
Q35203134 | Protein domain-level landscape of cancer-type-specific somatic mutations |
Q64967550 | Protein ensembles link genotype to phenotype. |
Q35824701 | Protein-protein interactions as drug targets |
Q35941833 | Quantitative interactome analysis reveals a chemoresistant edgotype |
Q64077530 | RMut: R package for a Boolean sensitivity analysis against various types of mutations |
Q90426893 | RNA Polymerase II CTD phosphatase Rtr1 fine-tunes transcription termination |
Q42781142 | Reasoning over genetic variance information in cause-and-effect models of neurodegenerative diseases |
Q87863250 | Regulome networks and mutational landscape in liver cancer: An informative path to precision medicine |
Q103002632 | Single-cell network biology for resolving cellular heterogeneity in human diseases |
Q52658141 | Systematic Functional Annotation of Somatic Mutations in Cancer. |
Q61450671 | Systematic domain-based aggregation of protein structures highlights DNA-, RNA- and other ligand-binding positions |
Q30584192 | Systematic exploration of ubiquitin sequence, E1 activation efficiency, and experimental fitness in yeast |
Q33976813 | Systems biology and the analysis of genetic variation |
Q37712293 | The cancer cell map initiative: defining the hallmark networks of cancer |
Q28573050 | The last enzyme of the de novo purine synthesis pathway 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (ATIC) plays a central role in insulin signaling and the Golgi/endosomes protein network |
Q35684524 | Tumor characterization and stratification by integrated molecular profiles reveals essential pan-cancer features |
Q35743304 | Unravelling personalized dysfunctional gene network of complex diseases based on differential network model |
Q30367833 | Viewing protein fitness landscapes through a next-gen lens. |
Q28771729 | Widespread macromolecular interaction perturbations in human genetic disorders |
Q48221341 | dSysMap: exploring the edgetic role of disease mutations |
Search more.